scholarly journals Supraventricular Tachycardia Ablation and Effects on Anxiety Medications

2021 ◽  
Author(s):  
Justin Haloot ◽  
Mohamed Mahmoud ◽  
Vanessa Rodriguez Fuenmayor ◽  
Mubeen Cheema ◽  
Auroa Badin
Keyword(s):  
Catheter Ablation ◽  
Anxiety Disorders ◽  
Supraventricular Tachycardia ◽  
Paroxysmal Supraventricular Tachycardia ◽  
Shortness Of Breath ◽  
Chest Discomfort ◽  
Final Study ◽  
Study Population

Background: Patients with true paroxysmal supraventricular tachycardia (SVT) are frequently misdiagnosed with panic or anxiety disorders due to similar symptoms of palpitations, light-headedness, dyspnea, or chest discomfort. Unrecognized SVT can lead to unnecessary management with anxiety medications. Treatment of SVT with catheter ablation may lead to reduction in anxiety medications. Methods: A total of 175 patients underwent successful SVT ablation between January 1, 2010 and December 31, 2020. We examined symptoms at presentation, psychiatric medications prior to SVT ablation, comorbidities, and psychiatric medications at 3 months post-ablation. Results: 15% of patients who underwent successful SVT ablation were being treated with psychiatric medications and were included in the final study population. The most common symptoms were palpitations (80.77%), followed by dizziness (42.31%), and shortness of breath (34.62%). The average number of medications prior to ablation was 1.42 and decreased down to 1.08 at 3 months post-ablation (p = 0.04). The average number of SSRIs, SNRIs, and other anxiolytics were also decreased but were not statistically significant. Conclusion: In patients with anxiety and paroxysmal supraventricular tachycardia, catheter ablation is associated with reduced average number of psychiatric medications.

scholarly journals Cost Effectiveness Analysis and Payment Policy Recommendation—Population-Based Survey with Big Data Methodology for Readmission Prevention of Patients with Paroxysmal Supraventricular Tachycardia treated with Radiofrequency Catheter Ablation

2020 ◽  
Vol 17 (7) ◽  
pp. 2334 ◽  
Author(s):  
Chien-Lung Chan ◽  
Ai-Hsien Adams Li ◽  
Hsiang-An Chung ◽  
Dinh-Van Phan
Keyword(s):  
Cost Effectiveness ◽  
Catheter Ablation ◽  
Incremental Cost ◽  
Supraventricular Tachycardia ◽  
Radiofrequency Catheter Ablation ◽  
Population Based ◽  
Paroxysmal Supraventricular Tachycardia ◽  
Research Database ◽  
Life Years ◽  
First Admission

Recurrence of paroxysmal supraventricular tachycardia (PSVT) has been reported to be lower in patients treated with radiofrequency catheter ablation (RFCA) than in those who are not. Few population-based surveys have stated the cost-effectiveness related to this treatment. We, therefore, performed a nationwide retrospective study using National Health Insurance Research Database (NHIRD) data from 2001–2012 in Taiwan. The incidence of PSVT-related admissions was computed from patients’ first admission for a primary PSVT diagnosis. There were 21,086 patients hospitalized due to first-time PSVT, of whom 13,075 underwent RFCA, with 374 recurrences (2.86%). In contrast, 1751 (21.86%) of the remaining 8011 patients who did not receive RFCA, most of whom had financial concerns, experienced PSVT recurrence. The relative PSVT recurrence risk in those who did not receive RFCA was 7.6 times (95% CI: 6.67–8.33) that of those who did undergo RFCA. In conclusion, the PSVT recurrence rate was much higher in patients who did not receive RFCA at their first admission. Furthermore, RFCA proved cost-effective, with the ratio of the incremental cost-effectiveness ratio (ICER) and gross domestic product (GDP) being only 1.15. To prevent readmission and avoid incremental cost, the authority could provide a financial supplement for every patient so that the procedure is performed, reducing the PSVT-recurrence life-years (disease-specific DALY).

Abstract 17883: Racial and Insurance disparities in Paroxysmal Supraventricular Tachycardia Ablation

Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Nileshkumar J Patel ◽  
Achint Patel ◽  
Neil Patel ◽  
Shantanu Solanki ◽  
Abhishek Deshmukh ◽  
...  
Keyword(s):  
Catheter Ablation ◽  
Supraventricular Tachycardia ◽  
Nationwide Inpatient Sample ◽  
Private Insurance ◽  
Multivariate Model ◽  
Teaching Hospitals ◽  
Paroxysmal Supraventricular Tachycardia ◽  
Racial Groups ◽  
Mixed Effect ◽  
Future Studies

Objective: To identify racial and/or health insurance disparities in the population undergoing ablation for paroxysmal supraventricular tachycardia(PSVT). Method: We identified adult patients (pts) admitted with principle diagnosis of PSVT by ICD 9 code 427.0 who had catheter ablation (ICD 9 code - 37.34), using the Nationwide Inpatient Sample (2000-2011). We stratified patients by race (White, Black, Hispanic, and other minority racial groups)and insurance status, and a hierarchical mixed effect multivariate model was created to identify independent predictors of PSVT ablation. Results: 64,564(20.2%) patients underwent ablation out of 319,579 patients admitted for PSVT during the period of 2000-2011. In absolute numbers, the majority of ablations were performed in Whites (58.7%) and patients with Medicare (56.3%) or private insurance (30.1%). After adjusting for confounding factors, the odds of having ablation were lower in Black pts (compare to White), and Medicare, Medicaid, and Uninsured pts (compare to private insurance) (see table). Other predictors of lower rate of ablations were: older age and female patients while odds of receiving ablation were higher for elective admissions and in teaching hospitals (p<0.001 for all comparisons). Conclusion: In a population of pts admitted for PSVT, those without private insurance and Black pts were less like to be treated with catheter ablation; and, this disparity persisted from 2000-2011. Since catheter ablation for PSVT is generally considered a curative procedure, future studies are needed to identify the factors that lead to these disparities of care.

A Case Report of Acupuncture at Neiguan Point (P6) for Paroxysmal Supraventricular Tachycardia

2020 ◽  
Vol 27 (5) ◽  
pp. 364-368
Author(s):  
Peizhong Liu ◽  
Chuangpeng Li ◽  
Yiting Lu ◽  
Qing Liu
Keyword(s):  
Case Report ◽  
Supraventricular Tachycardia ◽  
Acupuncture Treatment ◽  
Valsalva Maneuver ◽  
Medical Emergency ◽  
Paroxysmal Supraventricular Tachycardia ◽  
Shortness Of Breath ◽  
First Line ◽  
Accompanying Symptoms ◽  
First Line Treatment

Paroxysmal supraventricular tachycardia (PSVT) is a common medical emergency, and this case report describes an acupuncture treatment of traditional Chinese medicine terminating PSVT. In this case report, a 67-year-old female patient diagnosed with PSVT had a recurrence in the ward; accompanying symptoms were heart palpitations and shortness of breath. Modified Valsalva maneuver, the first-line treatment, failed to convert paroxysmal supraventricular tachycardia. However, acupuncture at Neiguan point (P6) for about 1 min on her right hand successfully treated the patient. This case indicates that the application of acupuncture in the clinic may serve as an alternative and complementary treatment for PSVT.

Sign in / Sign up

Export Citation Format

Share Document